Internal Med

sponsor

Topics in Internal Med

Academic Med/Education

Adolescent Medicine

Allergy/Immunology

Atherosclerosis/Lipids

Basic Science/Genetics

Clinical Pharmacology

Complementary Medicine

Critical Care/
Hospitalist

Economics of Medicine

Gastroenterology

Hematology/Oncology

Infectious Disease

Nephrology/Urology

Orthopedic/Physical Med

Pain Management

Preventive Medicine

Radiology/Diagnostics

Sports Medicine

Vascular Medicine

Weekly Messages E-mail

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Top Ten Searches

etanercept

hypertension

chf

antiphospholipid

fibrosis

mrsa

scid

renal cell

rickets

counterpulsation

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Denosumab update
Current Opinion in Rheumatology, 06/11/09

Lewiecki EM - Denosumab is a promising therapeutic agent for the management of postmenopausal osteoporosis and rheumatoid arthritis.

<< Previous
Genetically Elevated Lipoprotein(a) and Increased Risk of...

Next >>
Dutasteride shown to reduce prostate cancer in high-risk men

Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09

See All of Clinical Pharmacology

Today in Rheumatology...keeping you current

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09

See All of Rheumatology

Today in Women`s Health...keeping you current

Biphasic effects of hormone treatment on risk of cardiovascular disease
Sexuality, Reproduction & Menopause, 10/20/09

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
New England Journal of Medicine, 09/23/09

Risk factors for development of coronary artery disease in women with systemic lupus erythematosus
Journal of Rheumatology, 10/19/09

See All of Women`s Health

Sponsor

Article Search

Sponsor

Sponsor

Send this Summary to a Colleague